New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...

One local scout is working to brighten up the community. Around 7 a.m. Saturday, 20 volunteers and La Quinta city workers ...

Compass Pathways (NASDAQ:CMPS) executives outlined the company’s latest Phase 3 depression data and commercialization preparations during a Needham conference session moderated by biotech analyst Ami ...

Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate ...

Unprecedented,” “remarkable” and “transformative” were just a few of the descriptives tossed out by Wall Street analysts in response to Revolution Medicines Inc.’s phase III readout, showing RAS ...

A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.

Have you ever wondered how mussels instantly glue themselves to rocks, allowing them to survive the crushing force of ocean ...

Motor function improved with a favorable safety profile for patients with Parkinson’s disease who used tavapadon while receiving oral levodopa, according to a study published in JAMA Neurology.This ...

Most insurance firms are struggling to reap results from their generative AI initiatives as they look to the technology to ...

In the phase 2 trial, efficacy was also seen in patients with non-atopic chronic hand eczema treated with the oral JAK ...

More electric vehicle chargers will start popping up along major Texas roadways and in rural communities as part of a $5 ...

Abstract: The experimental results of phase-locked magnetrons reveal that, under identical operating conditions and phase-locking structures, discrepancies in output power between magnetrons correlate ...